DOCSLIB.ORG

Stable Isotopes for Mass Spectrometry Catalogue

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Stable Isotopes for Mass Spectrometry Catalogue Cambridge Isotope Laboratories, Inc. Stable Isotopes for Mass Spectrometry Proteomics Metabolism/Metabolomics MS/MS Standards Environmental Analysis Enriching Scientific Discovery MS_CATALOG 4/14 Supersedes all previously published literature isotope.com Welcome Welcome Over the past decade, there have been vast improvements in the detection and quantification of proteins, metabolites and potential biomarkers using mass spectrometry-based methodologies. Advances in bioinformatics and instrumentation, combined with the use of stable isotopes, have furthered the development, sensitivity and accuracy of quantitative methods. It is with great pride that we present Cambridge Isotope Laboratories, Inc.’s (CIL) new “Stable Isotopes for Mass Spectrometry” catalog. In this catalog, you will find a comprehensive listing of our isotope-enriched products that can be utilized for a wide range of mass spectrometry-based fields of research, including proteomics, metabolism, metabolomics, clinical diagnostics and environmental analysis. Complementing the extensive product listing are contributions written from some of the world’s most prominent mass spectrometrists, biochemists and research scientists. We are delighted to showcase application notes, customer perspectives and testimonials from many leaders in the field, illustrating the utility of stable isotopes. We would like to thank and show our appreciation to the many researchers who have contributed to this catalog. Please see page 163 for a complete list of contributors. CIL continues to maintain a leadership role in developing new products to study proteins, protein turnover, metabolic disorders and environmental contaminants. It has been through our partnerships and close relationships with our customers over the past 30 years that we have been able to significantly expand our product offering in order to assist this community in the advancement of their studies utilizing stable isotope-labeled compounds as a tool in mass spectrometry. We welcome suggestions from our customers for new products, which will advance their research. Our business is stable isotopes, but our focus is you, the customer. Thank you for giving us the opportunity to partner with you since 1981. You have truly made our success possible. Tasha Agreste Proteomics Product Manager Krista Backiel Metabolic Product Manager Carol Beland MS / MS Standards Product Manager Terry Grim Environmental Product Manager Tasha Agreste, Carol Beland, Terry Grim and Krista Backiel Cover illustration by Pedro Lalli www.isotope.com | [email protected] 1 Cambridge Isotope Laboratories, Inc. 2 tel: +1-978-749-8000 | 800-322-1174 (USA) | fax: +1-978-749-2768 isotope.com Corporate Overview Corporate Overview Cambridge Isotope Laboratories, Inc. (CIL) is the world leader in the separation and manufacture of stable isotopes and stable isotope-labeled compounds. With over 400 employees and laboratories in four countries, CIL specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (non-radioactive) isotopes of carbon, hydrogen, nitrogen and oxygen. Our chemists substitute a common atom for a rare, highly valued isotopic component so that the final product can be readily measured or traced using mass spectrometry (mass spec) or nuclear magnetic resonance (NMR). CIL’s products are utilized in laboratories, medical, government and academic research centers and health care facilities worldwide. We are proud that CIL products have contributed to medical advancements in cancer research, new drug development, environmental analysis, genomics and proteomics and medical diagnostic research. In the past decade, as the fields of proteomics and metabolomics CIL’s state-of-the-art production facilities are located at the have developed as leading techniques for determining bio­­­- company’s headquarters in Tewksbury, Massachusetts, and the markers for disease presence, progression and the monitoring company’s primary production laboratories are in Andover, of therapeutic response, CIL has worked closely with industry Massachusetts. Our isotope-separation facility located in Xenia, leaders and researchers to provide the stable isotope-labeled Ohio, houses the world’s largest 13C and 18O isotope-separation tools needed for improved quantitation of complex systems. facilities and the world’s only commercial D2O enrichment columns. CIL’s vision began when it was founded in 1981 by Dr. Joel Bradley, an organic chemist from MIT. Drawing on a commitment to high Dr. Bradley and the CIL Executive Team all share the same quality products, superior customer service, innovative new commitment to quality and service. Our experts collaborate products and breadth of product lines, CIL quickly emerged as a with all of our customers to aid in pivotal research that is being leader in its field. CIL now produces more than 15,000 products conducted in laboratories worldwide. Our partnerships not only and has ISO 13485 quality systems, as well as cGMP production help to support our global reach, but allow us to bring forward capabilities. Over the past several decades CIL has increased its innovative products to aid our customers’ pursuit of scientific global footprint and now has over 400 employees in its facilities discovery. located in four countries. The CIL group is comprised of six companies: Cambridge Isotope Laboratories, Inc. (CIL), CIL Isotope Separations (CIS) and Membrane Receptor Technologies (MRT) in the US; CIL Canada, Inc. in Montreal, Canada; Euriso-Top in Saclay, France; and ABX GmbH in Dresden, Germany. www.isotope.com | [email protected] 3 Cambridge Isotope Laboratories, Inc. General Information Cambridge Isotope Laboratories, Inc. Facilities Cambridge Isotope Laboratories, Inc. (CIL) has state-of-the-art production facilities for cGMP and non-cGMP manufacturing at its locations in Andover and Tewksbury, Massachusetts. CIL WORLD HEADQUARTERS AND cGMP PRODUCTION LABORATORIES TEWKSBURY, MA USA Cambridge Isotope Laboratories, Inc. moved into its new Tewksbury, Massachusetts facility in the spring of 2013. As our new corporate headquarters, this 40,000-square-foot facility houses our executive team as well as our sales, marketing, finance, regulatory affairs and cGMP production staff. In addition to corporate office space, the facility has a 10,000- square-foot state-of-the-art cGMP suite which includes production laboratories, dedicated isolation rooms, a dedicated analytical laboratory, a packaging laboratory and a development laboratory. CIL PRODUCTION LABORATORIES ANDOVER, MA USA CIL’s primary production facility in Andover, Massachusetts is dedicated to the manufacture of deuterated NMR solvents, stable isotope-labeled chemicals and gases, as well as specific cGMP products. This 57,000-square-foot facility is home to our operations staff and our production and quality-control teams. The formulations group has years of experience formulating highly purified labeled materials into high quality quantitative solutions as analytical standards, either as single-component products or multi-component mixes and calibration solutions. The quality-control lab is equipped with a wide array of instrumentation, including gas chromatograph / mass spectrometers (GC / MS), high field NMRs, HPLCs and an FT-IR. CIL’s chemistry laboratories are equipped with apparatus for both large scale (50+ liters) and microscale chemistry, including equipment for high pressure gas reactions, pH and temperature-controlled enzyme chemistry, high resolution distillation processes and catalytic reduction with both hydrogen and deuterium. The production laboratories are also equipped with analytical equipment for in-process testing, including GC-FID, GC-ECD and HPLC with UV, RI, ELSD and MS detectors. All of these resources allow CIL to consistently produce products with high chemical and isotopic purity. 4 tel: +1-978-749-8000 | 800-322-1174 (USA) | fax: +1-978-749-2768 isotope.com General Information CIL ISOTOPE SEPARATIONS, LLC (CIS) CIS CARBON-13 ISOTOPE CIS OXYGEN-18 ISOTOPE FACILITY, XENIA, OH USA SEPARATION FACILITY SEPARATION FACILITY CIL is the world leader in the separation CIL is recognized as the world leader in the In 2000, CIL responded to the worldwide of 13C and 18O. CIL separates both 13C separation of 13C. In the 1980s, CIL took the shortage of 18O water by embarking on and 18O at its Xenia, OH, facility and has initiative to construct the world’s largest 13C the construction of the world’s largest 18O the world’s largest production capacity isotope-separation plant in order to provide isotope-separation facility. Responding for both 13C and 18O. CIL also has the a sufficient supply of 13C starting materials to the increasing needs of the nuclear only non-governmental D2O enrichment to support new research and diagnostic medicine community, CIL has increased columns in the world located at its developments. In 2013, CIL embarked on a production capacity of 18O multiple times CIS facility. significant expansion of its 13C production since 2000. With each expansion, CIL has capacity and maintains its leadership maintained its position as the world’s position in the separation of 13C. leading producer of 18O. CIL’s 18O water is used in Positron Emission Tomography (PET) and energy-expenditure studies. EURISO-TOP CIL CANADA, INC. ABX GMBH SACLAY, FRANCE MONTREAL, CANADA DRESDEN, GERMANY Euriso-Top is Europe’s leading producer of CIL Canada, Inc. is CIL‘s biotech laboratory ABX is the world’s leading supplier of deuterated
Load more

Recommended publications
  • Stable Isotope-Labeled Productsfor Metabolic Research
    RESEARCH PRODUCTS Cambridge Isotope Laboratories, Inc. isotope.com Stable Isotope-Labeled Products For Metabolic Research Cambridge Isotope Laboratories, Inc. North America: 1.800.322.1174 [email protected] | International: +1.978.749.8000 [email protected] | fax: 1.978.749.2768 | isotope.com Cambridge Isotope Laboratories, Inc. | Stable Isotope-Labeled Products for Metabolic Research Stable Isotopes in Metabolomics and Metabolism Gary J. Patti Department of Chemistry, Washington University, St. Louis, Missouri 63130 United States Recent advances in mass spectrometry (MS) and nuclear comparing two sample groups, for example, an elevated magnetic resonance (NMR) technologies have greatly metabolite level may indicate increased or decreased enhanced metabolite analysis. Hundreds to thousands pathway flux. This is because metabolites can accumulate of metabolites can now be measured simultaneously with not only due to increased production, but also due to unprecedented accuracy from exceedingly small amounts decreased consumption. Yet, the difference between of biological material. These technical developments have increased production and decreased consumption may yield given rise to the field of metabolomics, which generally entirely different experimental interpretations. In a biomedical aims to assess metabolic regulation as a function of health context, for instance, increased production of a metabolite and disease. During the last decade, it has become relatively may suggest pharmacological inhibition of the pathway as a routine to perform metabolomic analysis on most biological therapeutic strategy. Thus, to understand pathway regulation samples. Interpretation of the acquired data, however, and metabolic mechanisms of disease, the application of remains a considerable challenge. Stable isotopes are isotopic tracers is required. providing experimental strategies that overcome some of these barriers.
    [Show full text]
  • Catalog Stable Isotope-Labeled Products for Metabolic Research
    Cambridge Isotope Laboratories, Inc. isotope.com Stable Isotope-Labeled Products For Metabolic Research Euriso-Top, Parc des Algorithmes, route de l'orme, 91190 Saint Aubin | France tel: +33 1 69 41 97 98 fax: +33 1 69 41 93 52 +49 (0) 681 99 63 338 (Germany) www.eurisotop.com Cambridge Isotope Laboratories, Inc. | Stable Isotope-Labeled Products for Metabolic Research Stable Isotopes in Metabolomics and Metabolism Gary J. Patti Department of Chemistry, Washington University, St. Louis, Missouri 63130 United States Recent advances in mass spectrometry (MS) and nuclear comparing two sample groups, for example, an elevated magnetic resonance (NMR) technologies have greatly metabolite level may indicate increased or decreased enhanced metabolite analysis. Hundreds to thousands pathway flux. This is because metabolites can accumulate of metabolites can now be measured simultaneously with not only due to increased production, but also due to unprecedented accuracy from exceedingly small amounts decreased consumption. Yet, the difference between of biological material. These technical developments have increased production and decreased consumption may yield given rise to the field of metabolomics, which generally entirely different experimental interpretations. In a biomedical aims to assess metabolic regulation as a function of health context, for instance, increased production of a metabolite and disease. During the last decade, it has become relatively may suggest pharmacological inhibition of the pathway as a routine to perform metabolomic analysis on most biological therapeutic strategy. Thus, to understand pathway regulation samples. Interpretation of the acquired data, however, and metabolic mechanisms of disease, the application of remains a considerable challenge. Stable isotopes are isotopic tracers is required.
    [Show full text]
  • Exploring the Activity of an Inhibitory Neurosteroid at GABAA Receptors
    1 Exploring the activity of an inhibitory neurosteroid at GABAA receptors Sandra Seljeset A thesis submitted to University College London for the Degree of Doctor of Philosophy November 2016 Department of Neuroscience, Physiology and Pharmacology University College London Gower Street WC1E 6BT 2 Declaration I, Sandra Seljeset, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I can confirm that this has been indicated in the thesis. 3 Abstract The GABAA receptor is the main mediator of inhibitory neurotransmission in the central nervous system. Its activity is regulated by various endogenous molecules that act either by directly modulating the receptor or by affecting the presynaptic release of GABA. Neurosteroids are an important class of endogenous modulators, and can either potentiate or inhibit GABAA receptor function. Whereas the binding site and physiological roles of the potentiating neurosteroids are well characterised, less is known about the role of inhibitory neurosteroids in modulating GABAA receptors. Using hippocampal cultures and recombinant GABAA receptors expressed in HEK cells, the binding and functional profile of the inhibitory neurosteroid pregnenolone sulphate (PS) were studied using whole-cell patch-clamp recordings. In HEK cells, PS inhibited steady-state GABA currents more than peak currents. Receptor subtype selectivity was minimal, except that the ρ1 receptor was largely insensitive. PS showed state-dependence but little voltage-sensitivity and did not compete with the open-channel blocker picrotoxinin for binding, suggesting that the channel pore is an unlikely binding site. By using ρ1-α1/β2/γ2L receptor chimeras and point mutations, the binding site for PS was probed.
    [Show full text]
  • ISOTEC® Stable Isotopes Biomolecular NMR Isotope Labeling Methods for Protein Dynamics Studies
    ISOTEC® Stable Isotopes Biomolecular NMR Isotope Labeling Methods for Protein Dynamics Studies Eric D. Watt and J. Patrick Loria, Ph.D. Department of Chemistry, Yale University, Kline Chemistry Laboratory, 225 Prospect Street, New Haven, CT 06520 Protein structure determination by solution NMR spectroscopy use of 15N-enriched minimal or nutrient-rich growth media that are has long relied on the uniform stable isotopic enrichment with readily available, allowing for easy sample preparation. Uniform 15N 13C and 15N to alleviate resonance overlap and to allow multiple labeling results in an isolated spin system (1H-15N) that lends itself well distance and angular restraints, at as many atomic sites as possible, to relaxation experiments. Every 15N position whether in the protein to facilitate computing the optimal three-dimensional structural backbone or sidechain is separated from another 15N atom by at least (1) 1 model. Recently, the optimization of these labeling techniques has two bonds. Therefore there are no JNN couplings that could lead to increased the range of protein sizes amendable to study, enhanced complicated multiexponential relaxation behavior, which would be the quality of three-dimensional structures, and simplified the analysis difficult to accurately measure and would cloud the interpretation of of experimental data.(2) Similarly, the field of protein dynamics has the associated motions. benefited from advances in isotopic labeling techniques that have However, 15N enrichment by itself does not provide a complete picture allowed researchers to study the motional properties of ever larger of the motions a protein undergoes. Nitrogen makes up only 1/3 of proteins over a broad range of timescales while more accurately the protein backbone and is only sparsely populated in the sidechains describing the protein motions.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • A Roadmap for Interpreting 13C Metabolite Labeling Patterns from Cells
    Available online at www.sciencedirect.com ScienceDirect 13 A roadmap for interpreting C metabolite labeling patterns from cells 1,2 3,* 4,* Joerg M Buescher , Maciek R Antoniewicz , Laszlo G Boros , 5,* 6,* 7,* Shawn C Burgess , Henri Brunengraber , Clary B Clish , 8,* 9,* 10,* Ralph J DeBerardinis , Olivier Feron , Christian Frezza , 1,2,* 11,* 12,* Bart Ghesquiere , Eyal Gottlieb , Karsten Hiller , 13,* 14,* 15,* Russell G Jones , Jurre J Kamphorst , Richard G Kibbey , 16,* 17,* 18,* Alec C Kimmelman , Jason W Locasale , Sophia Y Lunt , 11,* 19,* 20,* Oliver DK Maddocks , Craig Malloy , Christian M Metallo , 21,22,* 23,24,* Emmanuelle J Meuillet , Joshua Munger , 25,* 26,* 27,28,* Katharina No¨ h , Joshua D Rabinowitz , Markus Ralser , 29,* 30,* 31,* Uwe Sauer , Gregory Stephanopoulos , Julie St-Pierre , 32,* 33,* Daniel A Tennant , Christoph Wittmann , 34,35,* 11,* Matthew G Vander Heiden , Alexei Vazquez , 11,* 36,37,* 29,* Karen Vousden , Jamey D Young , Nicola Zamboni and 1,2 Sarah-Maria Fendt 13 Measuring intracellular metabolism has increasingly led to Goodman Cancer Research Centre, Department of Physiology, McGill 13 University, Montreal, QC, Canada important insights in biomedical research. C tracer analysis, 14 13 Institute of Cancer Sciences, University of Glasgow, Glasgow, UK although less information-rich than quantitative C flux 15 Internal Medicine, Cellular and Molecular Physiology, Yale University analysis that requires computational data integration, has been School of Medicine, New Haven, CT, USA 16 established as a time-efficient method to unravel relative Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA pathway activities, qualitative changes in pathway 17 Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA contributions, and nutrient contributions.
    [Show full text]
  • Stable Isotope Products for Metabolic Research
    Cambridge Isotope Laboratories, Inc. isotope.com RESEARCH PRODUCTS Stable Isotope Products for Metabolic Research • Amino Acids • Vitamins • Carbohydrates • MRS / MRI Products • Fatty Acids • Water • Steroids • Other Products To place an order please contact CIL: t: +1.978.749.8000 1.800.322.1174 (North America) [email protected] For international inquiries, please contact our International Customer Service Department at [email protected]. Cambridge Isotope Laboratories, Inc. CIL offers the most complete listing of stable isotopically labeled metabolic substrates available. These substrates are labeled with carbon-13, deuterium, nitrogen-15, oxygen-18, as well as other stable isotopes. Some of the many applications for these compounds include the utilization of amino acids for protein turnover studies, carbohydrates for glucose metabolism studies and fatty acids for lipolysis research. Researchers utilize a number of different methods to study metabolism including mass spectrometry, MRI and MRS. Isotope dilution mass spectrometry (IDMS) is arguably the most accurate, sensitive, reproducible and popular method available for quantifying small and intermediate-sized molecules in a wide range of sample types. One primary reason why compounds enriched in stable isotopes make ideal internal standards for comparative or absolute quantitation using mass spectrometry is that separate signals from the “heavy” (isotope enriched) and “light” (native) forms of the same compound are detected simultaneously. 13C and 15N nuclei are NMR active and thus compounds enriched in these isotopes allow for magnetic resonance detection. The large chemical shift range and favorable relaxation properties of the 13C nucleus have made 13C-enriched substrates highly valuable probes of cellular chemistry and metabolism, particularly in the rapidly advancing field of hyperpolarization.
    [Show full text]
  • RAC-GWVI: Research Alerts—Pubmed Citations for August 21 to 28, 2018 1
    RAC-GWVI: Research Alerts—PubMed Citations for August 21 to 28, 2018 1 GULF WAR ILLNESS Neurotoxicity in acute and repeated organophosphate exposure. Naughton SX1, Terry AV Jr2. Toxicology. 2018 Aug 22. pii: S0300-483X(18)30264-6. doi: 10.1016/j.tox.2018.08.011. PMID: 30144465. [Epub ahead of print] The term organophosphate (OP) refers to a diverse group of chemicals that are found in hundreds of products worldwide. As pesticides, their most common use, OPs are clearly beneficial for agricultural productivity and the control of deadly vector-borne illnesses. However, as a consequence of their widespread use, OPs are now among the most common synthetic chemicals detected in the environment as well as in animal and human tissues. This is an increasing environmental concern because many OPs are highly toxic and both accidental and intentional exposures to OPs resulting in deleterious health effects have been documented for decades. Some of these deleterious health effects include a variety of long-term neurological and psychiatric disturbances including impairments in attention, memory, and other domains of cognition. Moreover, some chronic illnesses that manifest these symptoms such as Gulf War Illness and Aerotoxic Syndrome have (at least in part) been attributed to OP exposure. In addition to acute acetylcholinesterase inhibition, OPs may affect a number of additional targets that lead to oxidative stress, axonal transport deficits, neuroinflammation, and autoimmunity. Some of these targets could be exploited for therapeutic purposes. The purpose of this review is thus to: 1) describe the important uses of organophosphate (OP)-based compounds worldwide, 2) provide an overview of the various risks and toxicology associated with OP exposure, particularly long-term neurologic and psychiatric symptoms, 3) discuss mechanisms of OP toxicity beyond cholinesterase inhibition, 4) review potential therapeutic strategies to reverse the acute toxicity and long term deleterious effects of OPs.
    [Show full text]
  • Calcium-Engaged Mechanisms of Nongenomic Action of Neurosteroids
    Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Rebas, Elzbieta, Tomasz Radzik, Tomasz Boczek, and Ludmila Zylinska. 2017. “Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids.” Current Neuropharmacology 15 (8): 1174-1191. doi:10.2174/1570159X15666170329091935. http:// dx.doi.org/10.2174/1570159X15666170329091935. Published Version doi:10.2174/1570159X15666170329091935 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:37160234 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA 1174 Send Orders for Reprints to [email protected] Current Neuropharmacology, 2017, 15, 1174-1191 REVIEW ARTICLE ISSN: 1570-159X eISSN: 1875-6190 Impact Factor: 3.365 Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids BENTHAM SCIENCE Elzbieta Rebas1, Tomasz Radzik1, Tomasz Boczek1,2 and Ludmila Zylinska1,* 1Department of Molecular Neurochemistry, Faculty of Health Sciences, Medical University of Lodz, Poland; 2Boston Children’s Hospital and Harvard Medical School, Boston, USA Abstract: Background: Neurosteroids form the unique group because of their dual mechanism of action. Classically, they bind to specific intracellular and/or nuclear receptors, and next modify genes transcription. Another mode of action is linked with the rapid effects induced at the plasma membrane level within seconds or milliseconds. The key molecules in neurotransmission are calcium ions, thereby we focus on the recent advances in understanding of complex signaling crosstalk between action of neurosteroids and calcium-engaged events.
    [Show full text]
  • Isotope Distributions
    Isotope distributions This exposition is based on: • R. Martin Smith: Understanding Mass Spectra. A Basic Approach. Wiley, 2nd edition 2004. [S04] • Exact masses and isotopic abundances can be found for example at http: //www.sisweb.com/referenc/source/exactmaa.htm or http://education. expasy.org/student_projects/isotopident/htdocs/motza.html • IUPAC Compendium of Chemical Terminology - the Gold Book. http:// goldbook.iupac.org/ [GoldBook] • Sebastian Bocker,¨ Zzuzsanna Liptak:´ Efficient Mass Decomposition. ACM Symposium on Applied Computing, 2005. [BL05] • Christian Huber, lectures given at Saarland University, 2005. [H05] • Wikipedia: http://en.wikipedia.org/, http://de.wikipedia.org/ 10000 Isotopes This lecture addresses some more combinatorial aspect of mass spectrometry re- lated to isotope distributions and mass decomposition. Most elements occur in nature as a mixture of isotopes. Isotopes are atom species of the same chemical element that have different masses. They have the same number of protons and electrons, but a different number of neutrons. The main ele- ments occurring in proteins are CHNOPS. A list of their naturally occurring isotopes is given below. Isotope Mass [Da] % Abundance Isotope Mass [Da] % Abundance 1H 1.007825 99.985 16O 15.994915 99.76 2H 2.014102 0.015 17O 16.999131 0.038 18O 17.999159 0.20 12C 12. (exact) 98.90 13C 13.003355 1.10 31P 30.973763 100. 14N 14.003074 99.63 32S 31.972072 95.02 15N 15.000109 0.37 33S 32.971459 0.75 34S 33.967868 4.21 10001 Isotopes (2) Note that the lightest isotope is also the most abundant one for these elements.
    [Show full text]
  • Large D/H Variations in Bacterial Lipids Reflect Central Metabolic Pathways
    Large D/H variations in bacterial lipids reflect central metabolic pathways Xinning Zhanga, Aimee L. Gillespieb, and Alex L. Sessionsa,b,1 aEnvironmental Science and Engineering Program and bDivision of Geological and Planetary Sciences, California Institute of Technology, Pasadena, CA 91125 This Feature Article is part of a series identified by the Editorial Board as reporting findings of exceptional significance. Edited by John M. Hayes, Woods Hole Oceanographic Institution, Woods Hole, MA, and approved May 29, 2009 (received for review March 19, 2009) Large hydrogen-isotopic (D/H) fractionations between lipids and compositions. Jones et al. (17) measured fatty acids extracted growth water have been observed in most organisms studied to from coastal marine particulate organic matter (POM) and date. These fractionations are generally attributed to isotope found ␦D values ranging from Ϫ73 to Ϫ237‰. Measurements effects in the biosynthesis of lipids, and are frequently assumed to of lipids from marine sediments have extended this range from be approximately constant for the purpose of reconstructing cli- Ϫ32 to Ϫ348‰ for lipids with n-alkyl skeletons and Ϫ148 to matic variables. Here, we report D/H fractionations between lipids Ϫ469‰ for those with isoprenoid skeletons (18). Because the and water in 4 cultured members of the phylum Proteobacteria, lipids measured by both studies likely derive from marine and show that they can vary by up to 500‰ in a single organism. organisms inhabiting seawater of essentially constant ␦D value The variation cannot be attributed to lipid biosynthesis as there is (Ϸ0‰), such differences cannot be due to varying environmen- no significant change in these pathways between cultures, nor can tal water.
    [Show full text]
  • Labeled Biological Standards for Quantitative Mass Spectrometry
    Cambridge Isotope Laboratories, Inc. isotope.com RESEARCH PRODUCTS Labeled Biological Standards for Quantitative Mass Spectrometry • Amino Acids • Fatty Acids and Lipids • Caffeine and Metabolites • Steroids and Hormones • Calibrant Gases • Other Metabolites and • Carnitine /Acylcarnitines Substrates To place an order please contact CIL: t: +1.978.749.8000 1.800.322.1174 (North America) [email protected] For international inquiries, please contact our International Customer Service Department at [email protected]. Cambridge Isotope Laboratories, Inc. RESEARCH PRODUCTS Amino Acids Catalog No. Description Catalog No. Description 13 NSK-A Labeled Amino Acid Standards Set A CDLM-9249 1-Methylxanthine ( C, 99%; D3, 98%) CP 97% 13 15 NSK-AB Labeled Standards Sets A & B CNLM-9252 1-Methylxanthine ( C4, 99%; N3, 98%) CNLM-9250 3-Methylxanthine (13C , 99%; 15N , 98%) DLM-248 L-Alanine (3,3,3-D3, 99%) 4 3 13 15 CNLM-9251 7-Methylxanthine (13C , 99%; 15N , 98%) CNLM-3946 β-Alanine ( C3, 98%+; N, 96-99%) 4 3 CNLM-9253 1,3,7-Trimethyluric acid (13C , 99%; 15N , 98%) DLM-1505 L-Allo-Isoleucine (D10, 98%) 4 3 DLM-541 L-Arginine·HCl (D7, 98%) DNLM-7543 L-Arginine HCl (D , 98%; 15N , 98%) · 7 4 Calibrant Gases CLM-2265-H L-Arginine HCl (13C , 99%) · 6 Catalog No. Description 13 15 CNLM-539-H L-Arginine·HCl ( C6, 99%; U- N4, 99%) CLM-3781 5% CO2 in air baseline calibrant gas DLM-546 L-Aspartic acid (2,3,3-D3, 98%) (with delta value = -22.71 vs. PDB) CDLM-7139 L-Citrulline (5-13C, 99%; 4,4,5,5-D , 95%) 4 CLM-3782 5% CO2 in air midlevel calibrant gas (vs.
    [Show full text]